Turkey's leading healthcare provider partners with Abraaj Capital to expand services in MENASA |
|
Acibadem Healthcare Services aims to become premier healthcare group in MENASA region
Abraaj CapitalAbraaj Capital
and Acibadem CEO acquire significant stake in Turkish firm through joint holding company
Abraaj CapitalAbraaj Capital acquisition made through Infrastructure and Growth Capital Fund
, the premier investment firm specialising in private equity investment in the Middle East, North Africa and South Asia (MENASA) region, announced today that it has partnered with Acibadem Healthcare Services, Turkey's leading healthcare provider, to support its ongoing expansion in Turkey and establish the company's presence in the Middle East. Almond AS, a 50:50 joint holding company formed by Abraaj CapitalAbraaj Capital and Mehmet Ali Aydinlar, one of the founders and the Chief Executive Officer of Acibadem, recently acquired a 69.6 per cent stake in the Turkish firm. Abraaj CapitalAbraaj Capital also acquired a 50 per cent stake in leading Turkish health insurance company, Acibadem Sigorta, from Mr. Aydinlar. Abraaj CapitalAbraaj Capital's investment was made through its US$2 billion Infrastructure and Growth Capital Fund (IGCF).
Acibadem, the only healthcare institution whose shares are traded on the Istanbul Stock Exchange, was founded in 1991 and is part of a premium integrated healthcare platform that provides secondary and tertiary private healthcare services, laboratory services, health and life insurance, hospital project management and hospital facilities management services. Its credentials include accreditation from Joint Commission International (JCI) and affiliation with Harvard Medical International. Acibadem Healthcare Services operates six premium hospitals with a bed capacity in excess of 700, two out-patient clinics, a central laboratory, a genetic and cell therapy lab, an ophthalmology center and five specialised medical centres. It is currently building another eight hospitals, which will take the total number of beds to 1,595.
The partnership between Acibadem and Abraaj CapitalAbraaj Capital will accelerate the development of the healthcare group in Turkey and facilitate the long-term expansion of its healthcare services in the MENASA region, where the existing supply of high-quality medical services is generally insufficient.
There are currently twice as many physicians per 1,000 people in the 30 countries within the OECD than there are in Turkey and in the GCC, and nearly three times the available hospital beds. In the GCC states alone, demand for treatment is expected to grow more than two-fold in the next 20 years, to approximately US$60 billion per annum by 2025.
Regional demand for healthcare services is being driven by a range of factors, including high levels of population growth, changing socio-demographics, prevalence of health risk factors, medical innovations and increasing insurance spend. In response to this growing demand, governments in the Middle East are increasingly focused on the provision of broadly available, high-quality services.
Today, regional governments are incentivising private-sector participation by creating an environment and regulatory framework conducive to investment in the sector. Private-sector organisations, such as Acibadem, will therefore play an increasingly important role in providing high-quality healthcare services for the fast-growing MENASA region.
Abraaj CapitalAbraaj Capital's entry into the healthcare sector is in line with the objectives of its Infrastructure and Growth Capital Fund, which seeks to address the infrastructure requirements of the MENASA region in various sectors, including transportation, education, water, manufacturing, petrochemicals, power and utilities, and healthcare.
"Historically, governments in the MENASA region have largely shouldered alone the burden of healthcare provision," said Arif Naqvi, Vice Chairman and Chief Executive Officer of Abraaj CapitalAbraaj Capital. "Given the high population growth rates, lower infant mortality rates and increased life expectancies, the need for the expansion of high-quality healthcare services has never been greater. Going forward, without private investment, the healthcare industry in the region will not be able to keep pace with this increasing demand.
"For nearly two decades, Acibadem has provided healthcare services to millions of people in Turkey," Naqvi added. "This investment significantly enhances the ability of Acibadem to expand its world-class services to the Middle East. At the same time, it demonstrates the importance Abraaj CapitalAbraaj Capital places on Turkey, an increasingly prosperous nation of more than 71 million, and in particular the Turkish healthcare sector. We are extremely pleased to announce such an important diversification of our portfolio as we work with Acibadem to expand the provision of high-quality healthcare services across Turkey and the wider MENASA region."
"We were able to identify the potential of the Turkish healthcare sector and to grow aggressively while maintaining the highest clinical standards. Our intention is to continue to expand in Turkey. We recognise, however, the signal opportunity to meet the healthcare needs of the people of the Middle East and have been receiving patients from the region, especially Bahrain, for some years now. We will now strive to duplicate what we have achieved in Turkey," said Mehmet Ali Aydinlar, Acibadem's founder and Chief Executive Officer.
"The partnership with Abraaj provides us with both expansion capital and the benefit of an unparalleled regional knowledge and network, and we are confident that, together, Acibadem and Abraaj CapitalAbraaj Capital can help the people of the region live longer, healthier lives."
-Ends-
About Abraaj CapitalAbraaj Capital:
Abraaj CapitalAbraaj Capital is the premier investment firm specialising in private equity investment in the Middle East, North Africa and South Asia (MENASA) region. The management team has brought together some of the most compelling and successful transactions in the history of leveraged acquisitions across the region.
With over US$5 billion of assets currently under management, Abraaj has pioneered institutionalizing private equity practice in the region and is setting trends and benchmarks for others to follow.
Winner of industry awards including 'Middle East Private Equity Firm of the Year' from Private Equity International (2006 & 2007), the Banker Middle East Award for 'Best Private Equities Institution' in 2006 and for 'Outstanding Contribution to Financial Services in the Middle East' in 2007 and 'Best Private Equity House' at the World Private Equity Awards, MENA in 2007. Arabian Business recognized Abraaj among the 50 Most Admired Companies in the GCC in 2007. Abraaj is also the first pure private equity firm to be registered by DFSA to operate out of Dubai International Financial Centre (DIFC).
Apart from managing its seven private equity funds, Abraaj CapitalAbraaj Capital Holdings Limited (ACHL) itself is extremely well capitalized, with an issued share capital of US$1 billion. Its 135 professionals come from 27 nationalities and achieve a coverage that spans the MENASA region. For more information please visit www.abraaj.com
About Acibadem Health Services:
Turkey's leading healthcare institution, Acibadem operates with over 6,000 employees in 20 different locations through a network of six general hospitals, medical centres, outpatient clinics, an ophthalmology center and laboratories. In addition to its partnerships with Istanbul International Hospital and International Etiler Outpatient Clinic, Acibadem is expanding its services continuously outside of Istanbul with Izmir, Eski?ehir and Bodrum Hospitals, and in Istanbul with Maslak and Be?ikta? (Fulya) Hospitals. For further information, please visit www.acibadem.com.tr/English/
For further information about Abraaj CapitalAbraaj Capital, please contact:
Nicholas Nesson / Rick Todd / Ghaleb Zeidan
ASDA'A Public Relations
Exclusive Affiliate of Edelman, Middle East & North Africa
Dubai, UAE
Tel: 971-4-3355969
Fax: 971-4-3356080
E-mail: n.nesson@asdaa.com / r.todd@asdaa.com / g.zeidan@asdaa.com
© Press Release 2008
from ASDA'A Public Relations
Comment on this article 
Loading ...-
Zawya encourages you to add a comment to this discussion. You agree that when you add content to this discussion your comments will not:
1.1 Contain any material which is libelous or defamatory of any person, is obscene, offensive, hateful or inflammatory or causes damage to the reputation of any person or organisation.
1.2 Promote sexually explicit material, violence, discrimination based on race, sex, religion, nationality, disability, sexual orientation or age or any illegal activity.
1.3 Be made in breach of any legal duty owed to a third party, such as a contractual duty or a duty of confidence.
1.4 Be threatening, abuse or invade another’s privacy, or cause annoyance, inconvenience or needless anxiety.
1.5 Be used to impersonate any person, to misrepresent your identity or affiliation with any person, or be likely to deceive any person.
1.6 Give the impression that they represent Zawya.
1.7 Advocate, promote or assist any unlawful act such as (by way of example only) copyright infringement or computer misuse. - The content posted on www.zawya.com is created by members of the public. The views expressed are theirs and unless specifically stated are not those of Zawya. Zawya reserves the right to review all comments prior to posting and edit or delete any contribution, but Zawya is not responsible for and can not be held liable for any content posted by members of the public on www.zawya.com.
- Zawya is not responsible for the availability or content of any third party sites that are accessible through www.zawya.com. Any links to third party websites from www.zawya.com do not amount to any endorsement of that site by Zawya and any use of that site by you is at your own risk.
- By submitting your comment, you hereby give Zawya the right, but not the obligation, to post, air, edit, exhibit, telecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comments worldwide, in perpetuity.
Stories
Loading...Companies
Loading...Projects
Loading...Blogs
Loading...Private Equity Monitor
| Infrastructure and Growth Capital Fund |
View Details  |